Spire Healthcare Group (LON:SPI – Get Free Report) released its quarterly earnings results on Wednesday. The company reported GBX (0.50) EPS for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%.
Spire Healthcare Group Stock Up 0.4%
Shares of SPI traded up GBX 1 during mid-day trading on Wednesday, reaching GBX 246.50. The company’s stock had a trading volume of 32,711,000 shares, compared to its average volume of 5,568,051. Spire Healthcare Group has a 12-month low of GBX 140.80 and a 12-month high of GBX 251.50. The stock has a market cap of £987.47 million, a PE ratio of 61.62, a price-to-earnings-growth ratio of 1.06 and a beta of 0.93. The company has a debt-to-equity ratio of 177.14, a current ratio of 0.63 and a quick ratio of 0.73. The company’s 50 day moving average is GBX 237.57 and its 200 day moving average is GBX 207.17.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada downgraded Spire Healthcare Group to a “sector perform” rating and dropped their target price for the company from GBX 300 to GBX 250 in a research report on Monday, September 7th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Spire Healthcare Group has an average rating of “Moderate Buy” and an average price target of GBX 247.50.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Recommended Stories
- Five stocks we like better than Spire Healthcare Group
- 3 Emerging Biotech Stocks With Significant Upside Potential
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
- 3 Healthcare Dividend Stocks Offering More Than Just Income
- AI Uncertainty Is Rising, But These 3 Chip ETFs Still Have Momentum
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
